Zika Virus Envelope, Recombinant, African Strain, aa291-690
Catalog No : USB-367952
633.35€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Zika Virus Envelope, Recombinant, African Strain, aa291-690 | ||
|---|---|---|---|
| Catalog No | USB-367952 | ||
| Supplier’s Catalog No | 367952 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, Insect cells | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 50 | ||
| Storage | -20°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | Purified (~85%) | ||
| Form | Supplied as liquid in PBS, pH 7.4, 0.05% sodium azide. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | Purified (~85%) | ||
| Description | Zika virus spreads to people primarily through the bite of an infected Aedes species mosquito, but it can also be sexually transmitted. Zika virus was first discovered in 1947 and is named after the Zika Forest in Uganda. In 1952, the first human cases of Zika were detected. Zika virus has become a highly researched disease due to increase in incidences from 2007 to 2016, when the virus spread eastward, across the Pacific Ocean to the Americas. In 2015–16 Zika virus epidemic reached pandemic levels. The Zika envelope (E) protein composes the majority of the virion surface and it is involved with replication, such as host cell binding and membrane fusion. The symptoms of Zika infection vary from non-existant to visible rash, fever, headaches and conjunctivitis. It is usually non life threatening, but has been associated to microcephaly in unborn fetuses when passed by an infected pregnant mother. The sequence of the envelope protein is derived from the African strain (all strains share very high identity in this region). Source: Recombinant protein corresponding to Zika virus envelope (E protein) comprising aa291-690, expressed in Insect cells. Molecular Weight: ~50kD Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. | ||
Product Details
© 2020 Imugex All Rights Reserved